(JHCB) John Hancock - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US47804J8181

JHCB: Corporate Bonds, Investment-Grade Loans, Foreign Securities

The John Hancock Corporate Bond ETF (JHCB) is an exchange-traded fund that primarily focuses on investing in corporate bonds, allocating at least 80% of its net assets towards this asset class under normal market conditions. This investment strategy is geared towards generating returns through a diversified portfolio of corporate debt securities.

In addition to its core investment in corporate bonds, JHCB may diversify its portfolio by investing up to 20% of its net assets in investment-grade bank loans, including loan participations, as well as cash and cash equivalents. This flexibility allows the fund to adapt to varying market conditions and potentially capitalize on opportunities in other fixed-income segments.

The fund also has the ability to invest up to 10% of its total assets in securities denominated in foreign currencies, introducing a layer of international diversification and potentially hedging against domestic market fluctuations. This exposure to foreign currencies can impact the funds returns, as exchange rate movements can either positively or negatively affect the value of these securities.

From a technical analysis perspective, JHCBs recent price action indicates a relatively stable trend, with its short-term, medium-term, and long-term Simple Moving Averages (SMA20, SMA50, SMA200) closely aligned around $20.94. The Average True Range (ATR) of 0.16, or 0.74%, suggests moderate daily price volatility. Given the current price of $21.06, and considering the 52-week high and low of $21.41 and $19.76, respectively, it appears that JHCB is trading near its upper range, potentially indicating a level of strength in the corporate bond market.

Forecasting the future performance of JHCB involves analyzing both its technical indicators and fundamental data. With Assets Under Management (AUM) standing at $55.59 million, the fund demonstrates a manageable scale that can potentially allow for agile investment decisions. Considering the technical data, if JHCB continues to trade above its SMA200 of $20.92, it may indicate a sustained bullish trend. However, a break below this level could signal a reversal. Given the current ATR, a reasonable price target could be in the range of $21.22 (21.06 + 0.16) in the short term, assuming the trend continues. Conversely, a decline towards the SMA200 could present a buying opportunity, depending on broader market conditions and the outlook for corporate bonds.

Additional Sources for JHCB ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

JHCB ETF Overview

Market Cap in USD 56m
Category Corporate Bond
TER 0.29%
IPO / Inception 2021-03-30

JHCB ETF Ratings

Growth Rating 5.92
Fundamental -
Dividend Rating 74.3
Rel. Strength 5.87
Analysts -
Fair Price Momentum 21.05 USD
Fair Price DCF -

JHCB Dividends

Dividend Yield 12m 4.84%
Yield on Cost 5y 4.86%
Annual Growth 5y 14.37%
Payout Consistency 100.0%
Payout Ratio %

JHCB Growth Ratios

Growth Correlation 3m 69.6%
Growth Correlation 12m 40.9%
Growth Correlation 5y -12.2%
CAGR 5y 0.46%
CAGR/Max DD 5y 0.02
Sharpe Ratio 12m 1.11
Alpha 3.08
Beta 0.024
Volatility 7.10%
Current Volume 37.4k
Average Volume 20d 9.4k
What is the price of JHCB shares?
As of July 01, 2025, the stock is trading at USD 21.43 with a total of 37,420 shares traded.
Over the past week, the price has changed by +1.06%, over one month by +1.71%, over three months by +2.29% and over the past year by +7.95%.
Is John Hancock a good stock to buy?
Neither. Based on ValueRay´s Analyses, John Hancock is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 5.92 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of JHCB is around 21.05 USD . This means that JHCB is currently overvalued and has a potential downside of -1.77%.
Is JHCB a buy, sell or hold?
John Hancock has no consensus analysts rating.
What are the forecasts for JHCB share price target?
According to our own proprietary Forecast Model, JHCB John Hancock will be worth about 22.7 in July 2026. The stock is currently trading at 21.43. This means that the stock has a potential upside of +6.07%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 22.7 6.1%